← Leaderboards
Kathleen A Brady
University Of Pennsylvania
$19,925,741
Attributed
$19,925,741
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.3M · FY2005–18$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
CDC$18,923,203 · 10
NIH$1,002,538 · 2
By mechanism
U62$13,937,046 · 7
U1B$2,622,380 · 1
U01$2,363,777 · 2
K23$754,246 · 1
M01$248,292 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Ian Frank$25,757,892
- Rob R Macgregor$4,980,820
- Harvey Michael Friedman$28,257,678
- Robert Gross$16,941,227
- Pablo Tebas$38,856,630
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsAids TherapyShinglesHuman Therapy EvaluationClinical ResearchHuman SubjectActive ImmunizationLive VaccineVaricella Zoster VirusViral VaccinesDisease /Disorder Prevention /ControlCombination ChemotherapyComorbidityDisease /Disorder Proneness /RiskAntiviral AgentsAntiaids AgentMicroorganism Disease ChemotherapyOpportunistic InfectionsClinical TrialsData Collection Methodology /Evaluation
Grant awards (53)
Philadelphia Cooperative Agreement Re-engagement Controlled Trial$200,000
U01 · FY2018 · PS · contact PI
Philadelphia Cooperative Agreement Re-engagement Controlled Trial$645,540
U01 · FY2017 · PS · contact PI
Philadelphia Cooperative Agreement Re-engagement Controlled Trial$833,333
U01 · FY2016 · PS · contact PI
HIV/AIDS SURVEILLANCE, HIV INCIDENCE SURVEILLANCE, MOLECULAR HIV SURV$291,719
U62 · FY2016 · PS · contact PI
To continue an ongoing bio-behavioral surveillance system to monitor the HIV epidemic among highrisk populations, including MSM, IDU and heterosexuals.$95,674
U62 · FY2016 · PS · contact PI
HIV/AIDS SURVEILLANCE, HIV INCIDENCE SURVEILLANCE, MOLECULAR HIV SURV$1,236,870
U62 · FY2015 · PS · contact PI
National HIV Behavioral Surveillance System$614,418
U1B · FY2015 · PS · contact PI
Medical Monitoring Project of PLWHA using HIV Case Surveillance Based Sampling$480,639
U62 · FY2015 · PS · contact PI
HIV/AIDS SURVEILLANCE, HIV INCIDENCE SURVEILLANCE, MOLECULAR HIV SURV$1,236,870
U62 · FY2014 · PS · contact PI
PS09-937 MEDICAL MONITORING PROJECT (MMP)$411,694
U62 · FY2014 · PS · contact PI
National HIV Behavioral Surveillance System$409,584
U1B · FY2014 · PS · contact PI
Philadelphia Cooperative Agreement Re-engagement Controlled Trial$100,000
U01 · FY2014 · PS · contact PI
HIV/AIDS SURVEILLANCE, HIV INCIDENCE SURVEILLANCE, MOLECULAR HIV SURV$1,240,718
U62 · FY2013 · PS · contact PI
PS09-937 MEDICAL MONITORING PROJECT (MMP)$411,694
U62 · FY2013 · PS · contact PI
National HIV Behavioral Surveillance System$381,291
U1B · FY2013 · PS · contact PI
HIV/AIDS SURVEILLANCE$777,675
U62 · FY2012 · PS · contact PI
PS09-937 MEDICAL MONITORING PROJECT (MMP)$429,817
U62 · FY2012 · PS · contact PI
National HIV Behavioral Surveillance System$414,016
U1B · FY2012 · PS · contact PI
National HIV Behavioral Surveillance System$402,873
U1B · FY2012 · PS · contact PI
HIV/AIDS SURVEILLANCE$69,002
U62 · FY2012 · PS · contact PI
HIV/AIDS SURVEILLANCE$1,065,462
U62 · FY2011 · PS · contact PI
National HIV Behavioral Surveillance System$400,198
U1B · FY2011 · PS · contact PI
PS09-937 MEDICAL MONITORING PROJECT (MMP)$356,644
U62 · FY2011 · PS · contact PI
ENHANCED HIV/AIDS SURVEILLANCE FOR PERINATAL PREVENTION$116,129
U62 · FY2011 · PS · contact PI
HIV/AIDS SURVEILLANCE$110,852
U62 · FY2011 · PS · contact PI
HIV/AIDS SURVEILLANCE$960,631
U62 · FY2010 · PS · contact PI
PS09-937 MEDICAL MONITORING PROJECT (MMP)$431,288
U62 · FY2010 · PS · contact PI
PS08-001, NATIONAL HIV BEHAVIORAL SURVEILLANCE SYSTEM$364,952
U62 · FY2010 · PS · contact PI
HIV/AIDS SURVEILLANCE$136,330
U62 · FY2010 · PS · contact PI
ENHANCED HIV/AIDS SURVEILLANCE FOR PERINATAL PREVENTION$124,118
U62 · FY2010 · PS · contact PI
HIV/AIDS SURVEILLANCE$33,901
U62 · FY2010 · PS · contact PI
HIV/AIDS SURVEILLANCE, HIV INCIDENCE SURVEILLANCE, VARIANT$1,130,902
U62 · FY2009 · PS · contact PI
PS09-937 MEDICAL MONITORING PROJECT (MMP)$431,288
U62 · FY2009 · PS · contact PI
PS08-001, NATIONAL HIV BEHAVIORAL SURVEILLANCE$364,952
U62 · FY2009 · PS · contact PI
ENHANCED HIV/AIDS SURVEILLANCE FOR PERINATAL PREVENTION$124,118
U62 · FY2009 · PS · contact PI
PS05-085, Surv of HIV/AIDS Related Events Among Persons Not Receiving Care$104,963
U01 · FY2009 · PS · contact PI
HIV/AIDS SURVEILLANCE, HIV INCIDENCE SURVEILLANCE, VARIANT$1,149,753
U62 · FY2008 · PS · contact PI
PS08-001, NATIONAL HIV BEHAVIORAL SURVEILLANCE$353,354
U62 · FY2008 · PS · contact PI
PS05-085, Surv of HIV/AIDS Related Events Among Persons Not Receiving Care$199,585
U01 · FY2008 · PS · contact PI
PS05-085, Surv of HIV/AIDS Related Events Among Persons Not Receiving Care$71,364
U01 · FY2007 · PS · contact PI
PS05-085, Surv of HIV/AIDS Related Events Among Persons Not Receiving Care$208,992
U01 · FY2006 · PS · contact PI
Surveillance of HIV/AIDS Related Events Among Persons Not Receiving Care$0
U01 · FY2005 · PS
HERPES ZOSTER: THERAPY AND PROPHYLAXIS IN HIV INFECTION$150,762
K23 · FY2004 · RR
HERPES ZOSTER: THERAPY AND PROPHYLAXIS IN HIV INFECTION$153,289
K23 · FY2003 · RR
HERPES ZOSTER: THERAPY AND PROPHYLAXIS IN HIV INFECTION$151,391
K23 · FY2002 · RR
SAFETY % IMMUNE RESPONSE TO VZV VACCINE IN HIV INFECTION$124,146
M01 · FY2002 · RR
HERPES ZOSTER: THERAPY AND PROPHYLAXIS IN HIV INFECTION$157,091
K23 · FY2001 · RR
SAFETY % IMMUNE RESPONSE TO VZV VACCINE IN HIV INFECTION$124,146
M01 · FY2001 · RR
SAFETY % IMMUNE RESPONSE TO VZV VACCINE IN HIV INFECTION$0
M01 · FY2001 · RR
HERPES ZOSTER: THERAPY AND PROPHYLAXIS IN HIV INFECTION$141,713
K23 · FY2000 · RR
SAFETY % IMMUNE RESPONSE TO VZV VACCINE IN HIV INFECTION$0
M01 · FY2000 · RR
SAFETY % IMMUNE RESPONSE TO VZV VACCINE IN HIV INFECTION$0
M01 · FY2000 · RR
SAFETY % IMMUNE RESPONSE TO VZV VACCINE IN HIV INFECTION$0
M01 · FY2000 · RR